Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2025-05-08 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于益丰大药房连锁股份有限公司2024年度持续督导报告书
Regulatory Filings Classification · 95% confidence The document is titled as a "2024年度持续督导报告书" (2024 Annual Continuous Supervision Report) issued by the sponsor (中信证券股份有限公司) for the listed company 益丰大药房连锁股份有限公司. It details the continuous supervision activities related to the issuance and management of convertible bonds, including regulatory compliance, information disclosure review, and onsite inspections. The document is a formal report summarizing the sponsor's ongoing supervisory duties as required by securities regulations and stock exchange rules. It is not an annual report, audit report, or earnings release, nor is it an announcement or proxy material. The content aligns with a regulatory or supervisory report related to capital market activities, specifically continuous supervision by the sponsor during the bond issuance period. This type of document fits best under the category of Regulatory Filings (RNS), as it is a compliance and supervisory report that does not fit other specific categories like Annual Report or Capital/Financing Update. The document length is 2209 characters, which is relatively short but contains substantive supervisory content rather than just an announcement or certification. Therefore, the classification is RNS with high confidence.
2025-05-08 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司2024年度持续督导工作现场检查报告
Regulatory Filings
2025-05-08 Chinese
益丰药房投资者关系活动会议纪要（20250429）
Call Transcript Classification · 95% confidence The document is a detailed transcript of an investor relations activity meeting held via conference call, including company performance data, strategic directions, Q&A with investors, and participation details. It contains substantive financial data for 2024 and Q1 2025, operational updates, and management commentary. The format and content align with a Call Transcript (CT) rather than a formal Annual Report or Earnings Release, as it includes interactive Q&A and detailed discussion rather than a summarized earnings announcement or formal report. The document length is under 5,000 characters but contains detailed discussion and financial data, supporting classification as a Call Transcript rather than a brief announcement or report publication notice.
2025-04-30 Chinese
7-2024年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2024年度履职情况报告" (2024 Annual Performance Report) of the Board Audit Committee of Yifeng Pharmacy Chain Co., Ltd. It details the audit committee's activities, including meetings held, supervision and evaluation of the annual report audit, external auditor evaluation, internal audit guidance, review of financial reports, and internal control effectiveness. The document is a detailed report on the audit committee's work and oversight related to the company's annual audit and internal controls, rather than the annual report itself or an announcement of a report. It is not a certification or a brief announcement but a substantive report on audit committee activities. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and related information about applied accounting principles and internal controls, excluding the full annual report. The document length is 3310 characters, which is relatively short but contains detailed content about audit committee work, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-04-28 Chinese
益丰药房2024年经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Regulatory Filings
2025-04-28 Chinese
益丰药房关于为子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company providing guarantees for bank credit applications on behalf of its subsidiaries. It includes specifics about the guarantee amounts, the subsidiaries involved, their financial conditions, and the board's approval of the guarantee. There is no indication that this is a full financial report, audit report, or earnings release. It is not a regulatory certification or a report publication announcement. The content focuses on capital/financing activities related to guarantees for bank credit, which fits the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive financial and operational details about the guarantees, not just a brief notice or announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-04-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.